RF9 - Neuropeptide Y Receptor Antagonist - 生命科學(xué)試劑 - MedChemExpress_第1頁
RF9 - Neuropeptide Y Receptor Antagonist - 生命科學(xué)試劑 - MedChemExpress_第2頁
RF9 - Neuropeptide Y Receptor Antagonist - 生命科學(xué)試劑 - MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemERF9Cat. No.: HY-107382CAS No.: 876310-60-0分式: CHNO分量: 482.62作靶點: Neuropeptide Y Receptor作通路: GPCR/G Protein; Neuronal Signaling儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 150 mg/mL (310

2、.80 mM; Need ultrasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.0720 mL 10.3601 mL 20.7202 mL5 mM 0.4144 mL 2.0720 mL 4.1440 mL10 mM 0.2072 mL 1.0360 mL 2.0720 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 RF9種有效且有選擇性的神經(jīng)肽FF受體 (Neuropeptide FF receptor)

3、 拮抗劑 ,對于 hNPFF1R 和 hNPFF2R的 Ki 值分別為 585 和 759 nM。IC50 & Target Ki: 585 nM (hNPFF1R), 759 nM (hNPFF2R) 1體內(nèi)研究RF9 (10 g) infused alone does not result in a significant alteration of MAP or heart rate. Conversely, MAPand heart rate increases evoked by NPFF are significantly blocked when NPFF is applied

4、in conjunction with1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemERF9 1. It is worthy to note that RF9 (30 nmol) significantly reduces the hypothermia induced by morphine (5nmol) 2.PROTOCOLAnimal Rats: Rats (n=5) are catheterized for measurement of arterial blood pressure and receive an in-dwellin

5、gAdministration 1 cannula into the lateral cerebral ventricle. Arterial blood pressure and heart rate are continuously monitored.NPFF (10 g in 10 L of saline) is injected into the lateral ventricle over 15 to 20 sec. Control injections ofsaline (10 L) are carried out in the same animals. Upon return

6、 of blood pressure to baseline, RF9 (10 g) isinjected i.c.v., followed by another i.c.v. injection of NPFF with RF9. After 1.5 h., another i.c.v. infusion ofNPFF is repeated 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Simonin F, et al

7、. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated withhyperalgesia. Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):466-71.2. Wang YQ, et al. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice. Peptides. 2008Jul;29(7):1183-90.McePdfHeightCaution: Product has not been fully validated for medical applications.For research

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論